Our Online Journal features original pieces written and edited by our Online staff at Columbia. They are not representative of any views held by the Columbia Undergraduate Law Review Editorial Board.
What happens when a global emergency confronts intellectual property law? Medical companies obtain patents for innovative technology, which gives these companies legal ground for a lawsuit should another company produce the same good. But in a time of crisis, as we see now with the coronavirus pandemic, there is a need to produce essential equipment on a scale so massive and immediate that it necessitates removing a patent’s protections.
Read MoreAs a few of the many diagnostic companies that are pioneers of medical innovation in the modern age, these pharmaceutical businesses are rolling out new, precise drug therapies at an unprecedented rate to combat specific medical issues by introducing diagnostic methods based on new technologies. The current age of biotechnology continues to challenge lawmakers as innovation unfolds faster than the current existing protective legislature. But no legal issue is more prominent in the biotechnological industry than ownership rights to these new developments.
Read More
